Medidata, a Dassault Systèmes company, announced a new leadership structure. The strategic evolution is an opportunity to further long-term goals and growth to enhance customers’ ability to unlock greater value across the Dassault Systèmes portfolio, ultimately taking drug development to new heights, informed the company.
Pascal Daloz, an accomplished leader at Dassault Systèmes, was named CEO of Medidata. Daloz played a key role in the success of the acquisition of Medidata in 2019.
Michael Pray was named company COO. In his prior role as Medidata chief commercial officer, he was instrumental in the rapid growth of the company. Pray will lead the day-to-day operations at Medidata, and will work closely with Daloz to build a complete solution set serving the life sciences industry at large.
“Customers are asking to do more with Medidata, and we are evolving to meet their digital transformation needs. Building on the strong foundation that has been set over the last twenty years, we will continue to pioneer unmatched solutions across the life sciences lifecycle. We are extremely committed to this industry and will continue investing to achieve the vision that includes prevention to precision medicine and discovery to distribution, in order to be at the center of every patient journey,” said Pascal Daloz, CEO, Medidata.